+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anti-infectives Market by Product Type (Antibiotics, Antifungals, Antiparasitics), Indication (Bloodstream Infections, Gastrointestinal Infections, Respiratory Infections), Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Anti-infectives Market by Product Type (Antibiotics, Antifungals, Antiparasitics), Indication (Bloodstream Infections, Gastrointestinal Infections, Respiratory Infections), Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Sale

Anti-infectives Market by Product Type (Antibiotics, Antifungals, Antiparasitics), Indication (Bloodstream Infections, Gastrointestinal Infections, Respiratory Infections), Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015081
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The anti-infectives market is in a period of rapid adaptation, shaped by mounting resistance challenges, technological breakthroughs, and heightened regulatory engagement. Senior decision-makers must navigate shifting dynamics to inform their investments and safeguard clinical and commercial objectives.

Market Snapshot: Anti-Infectives Sector Growth and Trajectory

The anti-infectives market advanced from USD 131.43 billion in 2024 to USD 138.37 billion in 2025. With an expected compound annual growth rate (CAGR) of 5.23%, the market is on pace to reach USD 178.52 billion by 2030. This trend reflects both the rising global demand for effective anti-infective therapies and the sector’s resilience amid evolving healthcare demands.

Scope & Segmentation of the Anti-Infectives Market

This research delivers a comprehensive examination of the entire anti-infectives landscape, encompassing a diverse range of products, therapeutic areas, distribution channels, and regional trends. The market segmentation covers core product types, indications, administration methods, distribution outlets, and end-user categories, as outlined below:

  • Product Types: Antibiotics (aminoglycosides, beta-lactams, fluoroquinolones, macrolides, sulfonamides, tetracyclines), antifungals (allylamines, azoles, echinocandins, polyenes), antiparasitics (anthelmintics, antimalarials, antiprotozoals), antivirals (neuraminidase inhibitors, nucleoside analogues, polymerase inhibitors, protease inhibitors)
  • Indications: Bloodstream infections, gastrointestinal infections, respiratory infections (bronchitis, community-acquired pneumonia, hospital-acquired pneumonia), skin and soft tissue infections, urinary tract infections
  • Route of Administration: Inhalation, oral, parenteral, topical
  • Distribution Channels: Drug stores, hospital pharmacies, online pharmacies, retail pharmacies
  • End Users: Clinics, home care settings, hospitals
  • Geographies: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, and more), Asia-Pacific (China, India, Japan, Australia, South Korea, among others)
  • Prominent Companies: Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc, Roche Holding AG, Johnson & Johnson, Sanofi S.A., AstraZeneca plc, Novartis AG, Bayer Aktiengesellschaft, Astellas Pharma Inc.
  • Key Technologies: Rapid diagnostics, AI-enabled drug discovery, high-throughput screening, novel manufacturing processes

Key Takeaways for Senior Decision-Makers

  • The need for new anti-infective therapies is driving cross-sector collaborations among pharmaceutical, biotech, and public health stakeholders to accelerate innovation and address gaps in resistance management.
  • Technological integration, such as artificial intelligence and machine learning, is transforming drug discovery processes, improving accuracy in target identification, and shortening development cycles.
  • Expedited regulatory pathways and adaptive clinical trial designs are enabling faster approvals for novel compounds and innovative product formats, increasing competitive differentiation.
  • Market segmentation reveals shifting demand patterns based on therapeutic area, route of administration, and distribution strategy, emphasizing the importance of targeted investment in high-growth regions and indications.
  • Strategic regional approaches are vital as regulatory, reimbursement, and manufacturing landscapes vary across the Americas, EMEA, and Asia-Pacific, influencing product adoption and portfolio priorities.
  • Investment in manufacturing resilience and flexible supply models is emerging as a response to recent global supply disruptions and competitive pressures.

Tariff Impact: U.S. Policy Shifts and Global Supply Chain Adaptations

Recent adjustments to United States import tariffs in 2025 have altered cost structures for pharmaceutical inputs and finished goods. These changes prompted organizations to reevaluate sourcing strategies, invest in domestic capabilities, and renegotiate long-term procurement agreements. The ripple effects are observable across global distribution channels, with shifts in inventory management, regional diversification of manufacturing, and the strengthening of supply chain resilience becoming central to maintaining competitive positioning.

Methodology & Data Sources

This report harnesses a combination of structured primary interviews with industry stakeholders and extensive secondary research across peer-reviewed literature, regulatory filings, and industry databases. Triangulation of quantitative data and validation by expert panel discussions underpin the reliability and depth of findings.

Why This Report Matters

  • Provides actionable, segment-specific insights to inform strategic planning and optimize resource allocation across the anti-infectives value chain.
  • Delivers a transparent analysis of emerging technologies, policy shifts, and competitive landscapes to support risk mitigation and market entry decision-making.

Conclusion

Market participants can strengthen strategic direction by leveraging the detailed insights and actionable recommendations presented in this anti-infectives market analysis. Proactive adaptation and collaboration will be crucial in navigating ongoing changes and achieving sustainable growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emergence of novel oral small molecule antivirals targeting resistant influenza strains
5.2. Rapid adoption of long-acting injectable antibiotics for outpatient management of bacterial infections
5.3. Integration of AI-driven predictive diagnostics to optimize antibiotic stewardship in hospitals
5.4. Rising investment in phage therapy platforms to address multi-drug resistant bacterial outbreaks
5.5. Expansion of global access programs for novel antifungal agents in emerging markets experiencing high candidiasis burden
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Anti-infectives Market, by Product Type
8.1. Introduction
8.2. Antibiotics
8.2.1. Aminoglycosides
8.2.2. Beta Lactams
8.2.3. Fluoroquinolones
8.2.4. Macrolides
8.2.5. Sulfonamides
8.2.6. Tetracyclines
8.3. Antifungals
8.3.1. Allylamines
8.3.2. Azoles
8.3.3. Echinocandins
8.3.4. Polyenes
8.4. Antiparasitics
8.4.1. Anthelmintics
8.4.2. Antimalarials
8.4.3. Antiprotozoals
8.5. Antivirals
8.5.1. Neuraminidase Inhibitors
8.5.2. Nucleoside Analogues
8.5.3. Polymerase Inhibitors
8.5.4. Protease Inhibitors
9. Anti-infectives Market, by Indication
9.1. Introduction
9.2. Bloodstream Infections
9.3. Gastrointestinal Infections
9.4. Respiratory Infections
9.4.1. Bronchitis
9.4.2. Community Acquired Pneumonia
9.4.3. Hospital Acquired Pneumonia
9.5. Skin And Soft Tissue Infections
9.6. Urinary Tract Infections
10. Anti-infectives Market, by Route Of Administration
10.1. Introduction
10.2. Inhalation
10.3. Oral
10.4. Parenteral
10.5. Topical
11. Anti-infectives Market, by Distribution Channel
11.1. Introduction
11.2. Drug Stores
11.3. Hospital Pharmacies
11.4. Online Pharmacies
11.5. Retail Pharmacies
12. Anti-infectives Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Home Care Settings
12.4. Hospitals
13. Americas Anti-infectives Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Anti-infectives Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Anti-infectives Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Pfizer Inc.
16.3.2. Merck & Co., Inc.
16.3.3. GlaxoSmithKline plc
16.3.4. Roche Holding AG
16.3.5. Johnson & Johnson
16.3.6. Sanofi S.A.
16.3.7. AstraZeneca plc
16.3.8. Novartis AG
16.3.9. Bayer Aktiengesellschaft
16.3.10. Astellas Pharma Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ANTI-INFECTIVES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ANTI-INFECTIVES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ANTI-INFECTIVES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ANTI-INFECTIVES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ANTI-INFECTIVES MARKET: RESEARCHAI
FIGURE 26. ANTI-INFECTIVES MARKET: RESEARCHSTATISTICS
FIGURE 27. ANTI-INFECTIVES MARKET: RESEARCHCONTACTS
FIGURE 28. ANTI-INFECTIVES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ANTI-INFECTIVES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTI-INFECTIVES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANTI-INFECTIVES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY BETA LACTAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY BETA LACTAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY FLUOROQUINOLONES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY FLUOROQUINOLONES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY MACROLIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY SULFONAMIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY SULFONAMIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY TETRACYCLINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ALLYLAMINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ALLYLAMINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY AZOLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY AZOLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ECHINOCANDINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ECHINOCANDINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY POLYENES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY POLYENES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTHELMINTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTHELMINTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIMALARIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIMALARIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIPROTOZOALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIPROTOZOALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY NEURAMINIDASE INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY NEURAMINIDASE INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY NUCLEOSIDE ANALOGUES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY NUCLEOSIDE ANALOGUES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY POLYMERASE INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY POLYMERASE INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY PROTEASE INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY PROTEASE INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY BLOODSTREAM INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY BLOODSTREAM INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY BRONCHITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY BRONCHITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY COMMUNITY ACQUIRED PNEUMONIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY COMMUNITY ACQUIRED PNEUMONIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY HOSPITAL ACQUIRED PNEUMONIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY HOSPITAL ACQUIRED PNEUMONIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY SKIN AND SOFT TISSUE INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY SKIN AND SOFT TISSUE INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY INHALATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY PARENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY DRUG STORES, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES ANTI-INFECTIVES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 153. CANADA ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 154. CANADA ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 155. CANADA ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 156. CANADA ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 157. CANADA ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 158. CANADA ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 159. CANADA ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 160. CANADA ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 161. CANADA ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 162. CANADA ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 163. CANADA ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 164. CANADA ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 165. CANADA ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 166. CANADA ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 167. CANADA ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 168. CANADA ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 169. CANADA ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. CANADA ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. CANADA ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. CANADA ANTI-INFECTIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. MEXICO ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. MEXICO ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. MEXICO ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 176. MEXICO ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 177. MEXICO ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 178. MEXICO ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 179. MEXICO ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 180. MEXICO ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 181. MEXICO ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 182. MEXICO ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 183. MEXICO ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 184. MEXICO ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 185. MEXICO ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 186. MEXICO ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 187. MEXICO ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 188. MEXICO ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 189. MEXICO ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. MEXICO ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. MEXICO ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. MEXICO ANTI-INFECTIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL ANTI-INFECTIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA ANTI-INFECTIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM ANTI-INFECTIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. GERMANY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 276. GERMANY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 277. GERMANY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 278. GERMANY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 279. GERMANY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 280. GERMANY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 281. GERMANY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 282. GERMANY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 283. GERMANY ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 284. GERMANY ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 285. GERMANY ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 286. GERMANY ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 287. GERMANY ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 288. GERMANY ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 289. GERMANY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. GERMANY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. GERMANY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. GERMANY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. GERMANY ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. GERMANY ANTI-INFECTIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. FRANCE ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. FRANCE ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. FRANCE ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 298. FRANCE ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 299. FRANCE ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 300. FRANCE ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 301. FRANCE ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 302. FRANCE ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 303. FRANCE ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 304. FRANCE ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 305. FRANCE ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 306. FRANCE ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 307. FRANCE ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 308. FRANCE ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 309. FRANCE ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 310. FRANCE ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 311. FRANCE ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. FRANCE ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. FRANCE ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. FRANCE ANTI-INFECTIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 316. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 317. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 318. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 319. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 320. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 321. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 322. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 323. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 324. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 325. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 326. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 327. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 328. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 329. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 330. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 331. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 332. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 333. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 334. RUSSIA ANTI-INFECTIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 335. ITALY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 336. ITALY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 337. ITALY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
TABLE 338. ITALY ANTI-INFECTIVES MARKET SIZE, BY ANTIBIOTICS, 2025-2030 (USD MILLION)
TABLE 339. ITALY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2018-2024 (USD MILLION)
TABLE 340. ITALY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, 2025-2030 (USD MILLION)
TABLE 341. ITALY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2018-2024 (USD MILLION)
TABLE 342. ITALY ANTI-INFECTIVES MARKET SIZE, BY ANTIPARASITICS, 2025-2030 (USD MILLION)
TABLE 343. ITALY ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2018-2024 (USD MILLION)
TABLE 344. ITALY ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, 2025-2030 (USD MILLION)
TABLE 345. ITALY ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 346. ITALY ANTI-INFECTIVES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 347. ITALY ANTI-INFECTIVES MARKE

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Anti-infectives market report include:
  • Pfizer Inc.
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Roche Holding AG
  • Johnson & Johnson
  • Sanofi S.A.
  • AstraZeneca plc
  • Novartis AG
  • Bayer Aktiengesellschaft
  • Astellas Pharma Inc.

Table Information

Report AttributeDetails
No. of Pages181
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 138.37 Billion
Forecasted Market Value ( USD ) by 2030 $ 178.52 Billion
Compound Annual Growth Rate5.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Anti-Infective Agents Market Size, Share & Trends Analysis Report By Type (Antibacterial, Antiviral, Antifungal & Antiparasitic), By Route Of Administration (Oral, Parenteral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Anti-Infective Agents Market Size, Share & Trends Analysis Report By Type (Antibacterial, Antiviral, Antifungal & Antiparasitic), By Route Of Administration (Oral, Parenteral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 130 Pages
  • Global
From
Anti-infectives Market Report by Type, Route of Administration, Distribution Channel, and Region 2025-2033 - Product Image

Anti-infectives Market Report by Type, Route of Administration, Distribution Channel, and Region 2025-2033

  • Report
  • 136 Pages
  • Global
From
Pneumonia Therapeutics Market by Therapy Type (Adjunctive Therapies, Anti Infectives, Biologics), Route Of Administration (Inhalation, Intravenous, Oral), Distribution Channel, Patient Age Group, Pathogen Type, Indication Type - Global Forecast 2025-2030 - Product Image

Pneumonia Therapeutics Market by Therapy Type (Adjunctive Therapies, Anti Infectives, Biologics), Route Of Administration (Inhalation, Intravenous, Oral), Distribution Channel, Patient Age Group, Pathogen Type, Indication Type - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Anti-Infectives - Global Strategic Business Report - Product Image

Anti-Infectives - Global Strategic Business Report

  • Report
  • 116 Pages
  • Global
From
Anti-infective Endotracheal Tube Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Anti-infective Endotracheal Tube Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 87 Pages
  • Global
From

About the Infection Drug Market

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs. Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.